AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitazide M 50mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Innovative Pharmaceuticals

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitazide M 50mg/1000mg Tablet

Diabetic patients with type 2 mellitus can manage elevated blood glucose with the dual-action Sitazide M 50mg/1000mg tablet. This formulation mitigates severe diabetic complications like vision impairment and nephropathy, potentially lowering cardiovascular event risks (heart attack/stroke). Sitazide M 50mg/1000mg may be administered independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glycemic control, and concurrent medications. Consuming it with meals minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time, maximizes therapeutic benefits; discontinuation requires physician approval. Maintaining the prescribed dietary and exercise regimen is crucial for diabetes management; lifestyle choices are integral to successful glycemic control. Common adverse effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Concurrent use with insulin or sulfonylureas may induce hypoglycemia; learn its recognition and management. This medication isn't universally suitable. Prior to commencing therapy, inform your physician of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation. Drug interactions are possible; disclose all medications to ensure safety. Alcohol should be limited due to its hypoglycemic effects. Kidney function and blood glucose will be monitored by your physician throughout treatment.

Uses of Sitazide M 50mg/1000mg Tablet

Managing Type 2 diabetes

Major Benefits of Sitazide M 50mg/1000mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Sitazide M 50mg/1000mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Sitazide M 50mg/1000mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitazide M 50mg/1000mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Sitazide M 50mg/1000mg Tablet should be administered with a meal.

How Sitazide M 50mg/1000mg Tablet works:

Sitagliptin/metformin 50mg/1000mg tablets (Sitazide M) combine two distinct medications to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and heightens insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sitazide M 50mg/1000mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitazide M 50mg/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitazide M 50mg/1000mg tablets while breastfeeding is likely unsafe. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitazide M 50mg/1000mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. For individuals with severe kidney disease, Sitazide M 50mg/1000mg tablets are contraindicated. Routine monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Sitazide M 50mg/1000mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitazide M 50mg/1000mg Tablet :

Should you forget a Sitazide M 50mg/1000mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitazide M 50mg/1000mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Sitazide M 50mg/1000mg Tablet

Sitazide M 50mg/1000mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitazide M 50mg/1000mg Tablet use can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Sitazide M 50mg/1000mg tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitazide M 50mg/1000mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitazide M 50mg/1000mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitazide M 50mg/1000mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Sitazide M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitazide M 50mg/1000mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with allergies to Sitazide M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitazide M 50mg/1000mg tablets is unsafe due to the increased risk of lactic acidosis.
Sitagliptin/Metformin (Sitazide M 50mg/1000mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitazide M 50mg/1000mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medicine and keep it out of reach of children, pets, and others.
Sitazide M 50mg/1000mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitazide M 50mg/1000mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitazide M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitazide M 50mg/1000mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitazide M 50mg/1000mg) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitazide M 50mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Sitazide M 50mg/1000mg Ta...
448